Skip to main content

IPO Chilli Ratings

IPO Chilli Ratings
Click to understand how it works

Featured

Singapore Institute of Advanced Medicine Holdings Ltd

Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist.  The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am.   Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases.  SAM has strategic collaborations with public and private institutions for research and clinical work.  SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi

Yamada Green Resources Limited

Yamada Green Resources Limited “the Company” is offering 30.08m Vendor Shares and 74.9m New Shares of which 2m will be via public and the rest via placement.  The shares are priced at $0.22 each. The IPO will close on 6 Oct at12pm.

The Company is a major supplier of self-cultivated shitake mushrooms in Fujian Province PRC and operates one of the largest cultivation base there. Its products are broadly classified into mushrooms or processed food products.

Revenue grew from RMB 73m million in FY2007 to RMB 236.2m in FY2009 and net profit after tax grew from RMB10.4m to RM81.7m over the same period. The net margin improved from 14.2% to 34.6% during this period. The unaudited 3M 2010 revenue grew by another 63% and net profit grew  by 85% respectively over the same period in FY2009. 

Post IPO, the company intends to expand its cultivation base, expand its eucalyptus plantations and establish its own distribution and marketing network. There will be 406.6m shares post IPO, i rather they issue less shares and priced it higher. I guess the IPO managers are still of the view that investors believe "lower priced" China shares are 'better' as the down side risk is 'lesser'. I rather they be more confident in this regard. 

Based on the post IPO no. of shares, the company is listing at a historical PER of 5.23x (assuming the service agreement is in place in FY2009 based on the post-IPO shares). The market cap will be $89.45m.

Assuming the net profit increased by more than 50% in FY2010, this means the net profit will be RMB 122.5m. This will translate into a EPS of approximately 6 Singapore cents. Based on the IPO price of 22c, it is priced at a prospective PER of 3.67x which is very 'cheaply' priced.

Sinograndness (another listed S-chip in button mushroom) is trading at around 6.2x PE. Assuming Yamada trades at 5-6x prospective, it will translate into a fair price of 30-36c. But a few push back factors will be the vendor share sale and huge float. It will likely be another hit and run story. 

Comments

Anonymous said…
Isn't huge float good? More liquidity? Also saw on page 66 of prospectus, FY09 was based on 2,313 mu of cultivation land for mushroom and FY10 will be based on 2,614 mu.
Mr. IPO said…
Huge float means more difficult to control the selling... smaller float means can place out to strong hands and move the price up.... (just my personal view).
Clouddragon said…
First day performance not bad leh. You think will hold? Look like placee not selling so price maintained ... this week how?
Mr. IPO said…
well if i am allocated shares or got it from the IPO public tranche, i will be a seller at 35 or better.